Latest news with #WAT
Otago Daily Times
21-07-2025
- Entertainment
- Otago Daily Times
Sam Young claims art expo award
Sam Young was presented with the People's Choice winner's certificate by Mark Glanville, representing award sponsor John Rhind Kaiapoi, at the Corcoran French Kaiapoi Art Expo in Kaiapoi. PHOTO: NIKKI PARKER A Canterbury artist's work has won the hearts of visitors to the Corcoran French Kaiapoi Art Expo. Mandeville artist Sam Young's painting Incapable of Change was named the People's Choice award winner. It was the first time Sam - who was the guest artist at the 2023 expo - had won the prestigious award. ''I was runner up a few years ago, so it was great to get the most votes this time around,'' he says. ''I was very pleased with how this piece turned out and I was excited to get it on display to see how people reacted to it and it obviously stood out enough to get the votes.'' Sam always looks forward to the expo. ''It is a well-run event and is a great asset for the Waimakariri art scene.'' This year's event was held upstairs in the Kaiapoi Club. It ''couldn't have gone much better'' for Sam who also sold all of his pieces. ''It is always very satisfying selling out at a show and I really appreciate all the people who come through the doors to either buy art or to just have a look or to laugh at my stupid bio,'' he says. The expo, which was established in 2006, was organised by the Waimakariri Arts Trust and attracted large crowds to the town. ''Kaiapoi was absolutely buzzing,'' said WAT chair Jackie Watson. ''So many people took the opportunity to be inspired by our huge number of talented local artists. Every year the standard improves.'' Waimakariri Mayor Dan Gordon, who is known for purchasing local art and is a WAT trustee, was a guest speaker on the opening night of the expo last Friday. He said the small group of art lovers got together 19 years ago to see how they could promote art in Waimakariri - but never dreamed the expo would have such longevity. ''We never thought it would last this long or be so successful when we established it,'' he said. However, the popularity of the expo shows how art is very important to the community, too. Next year the expo will celebrate its 20th anniversary. Plans are already under way to hold an art extravaganza even more spectacular than the recent event.
Yahoo
14-07-2025
- Business
- Yahoo
What to Expect From Waters Corporation's Next Quarterly Earnings Report
Milford, Massachusetts-based Waters Corporation (WAT) provides analytical workflow solutions. With a market cap of $21 billion, the company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. The global analytical instrumentation leader is expected to announce its fiscal second-quarter earnings for 2025 before the market opens on Monday, Aug. 4. Ahead of the event, analysts expect WAT to report a profit of $2.92 per share on a diluted basis, up 11% from $2.63 per share in the year-ago quarter. The company has consistently surpassed Wall Street's EPS estimates in its last four quarterly reports. Shopify Stock is a Bargain - How to Make a 3.2% One-Month Yield with SHOP Tariffs, Inflation and Other Key Things to Watch this Week Stocks Set to Open Lower as Trump Ratchets Up Tariff Threats, U.S. Inflation Data and Big Bank Earnings Awaited Stop Missing Market Moves: Get the FREE Barchart Brief – your midday dose of stock movers, trending sectors, and actionable trade ideas, delivered right to your inbox. Sign Up Now! For the full year, analysts expect WAT to report EPS of $12.90, up 8.8% from $11.86 in fiscal 2024. Its EPS is expected to rise 10.2% year over year to $14.21 in fiscal 2026. WAT stock has outperformed the S&P 500 Index's ($SPX) 12.1% gains over the past 52 weeks, with shares up 17.1% during this period. Similarly, it outperformed the Health Care Select Sector SPDR Fund's (XLV) 8.3% dip over the same time frame. WAT's impressive performance can be attributed to its success in pharmaceutical markets, strong growth in instrument sales, and the ongoing popularity of its innovative product offerings. On May 6, WAT shares closed down more than 2% after reporting its Q1 results. Its adjusted EPS of $2.25 surpassed Wall Street expectations of $2.22. The company's revenue was $661.7 million, topping Wall Street forecasts of $654.6 million. The company expects full-year adjusted EPS in the range of $12.75 to $13.05. Analysts' consensus opinion on WAT stock is reasonably bullish, with a 'Moderate Buy' rating overall. Out of 18 analysts covering the stock, seven advise a 'Strong Buy' rating, and 11 give a 'Hold.' WAT's average analyst price target is $394.11, indicating a potential upside of 11.7% from the current levels. On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on
Yahoo
19-06-2025
- Business
- Yahoo
How Is Waters Corporation's Stock Performance Compared to Other Healthcare Stocks?
With a market cap of $20.2 billion, Waters Corporation (WAT) is a global leader in analytical instruments and laboratory solutions. Operating through its Waters and TA Divisions, the company designs, manufactures, and services high-performance liquid chromatography, mass spectrometry, and thermal analysis systems. Companies valued at more than $10 billion are generally considered 'large-cap' stocks, and Waters Corporation fits this criterion perfectly. Its innovative products support pharmaceutical, life science, industrial, and governmental customers across Asia, the Americas, and Europe in research, development, and quality assurance applications. OpenAI CEO Sam Altman Says 'We Are Heading Towards a World Where AI Will Just Have Unbelievable Context on Your Life' Archer Aviation Is Betting Big on Its Fledgling Defense Business. Does That Make ACHR Stock a Buy Here? Unusual Call Options Activity in Marvell Technology Highlights the Value of MRVL Stock Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else. Shares of the Milford, Massachusetts-based company have fallen 19.9% from its 52-week high of $423.56. Over the past three months, shares of WAT have declined 11.2%, underperforming the 9.3% dip of the Health Care Select Sector SPDR Fund (XLV) during the same period. Longer term, WAT stock is down 8.5% on a YTD basis, a steeper decline than XLV's 3.2% drop. However, shares of Waters Corporation have returned 15.3% over the past 52 weeks, surpassing XLV's 8.7% decline over the same time frame. The stock has been trading below its 200-day moving average since April. Despite reporting better-than-expected Q1 2025 adjusted EPS of $2.25 and revenue of $661.7 million, WAT shares fell 2.7% on May 6, likely due to investor concerns over macroeconomic uncertainties and tariff impacts. However, the company raised its full-year adjusted EPS guidance to $12.75 - $13.05 and constant currency sales growth to 5% - 7%. WAT stock has outperformed its rival, Thermo Fisher Scientific Inc. (TMO). TMO stock has fallen 31% over the past 52 weeks and 24.5% on a YTD basis. Despite the stock's outperformance over the past year, analysts are cautiously optimistic about its prospects. The stock has a consensus rating of 'Moderate Buy' from the 18 analysts covering the stock, and as of writing, it is trading below the mean price target of $393. On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on
Yahoo
28-05-2025
- Business
- Yahoo
Why Waters (WAT) is a Top Growth Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing methodologies, namely value, growth, and momentum. The Style Scores can help you narrow down which stocks are better for your portfolio and which ones can beat the market over the long-term. For growth investors, a company's financial strength, overall health, and future outlook take precedence, so they'll want to zero in on the Growth Style Score. This Score examines things like projected and historical earnings, sales, and cash flow to find stocks that will generate sustainable growth over time. Milford, MA-based, Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. WAT boasts a Growth Style Score of A and VGM Score of B, and holds a Zacks Rank #3 (Hold) rating. Its bottom-line is projected to rise 8.7% year-over-year for 2025, while Wall Street anticipates its top line to improve by 5.1%. Four analysts revised their earnings estimate upwards in the last 60 days for fiscal 2025. The Zacks Consensus Estimate has increased $0.01 to $12.89 per share. WAT boasts an average earnings surprise of 4%. Looking at cash flow, Waters is expected to report cash flow growth of 4.1% this year; WAT has generated cash flow growth of 4.6% over the past three to five years. Investors should take the time to consider WAT for their portfolios due to its solid Zacks Rank rating, notable growth metrics, and impressive Growth and VGM Style Scores. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Waters Corporation (WAT) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Time of India
22-05-2025
- Science
- Time of India
Symbiosis SET 2025 result declared: Direct link to download scorecards here
Symbiosis SET result 2025 : The Symbiosis International (Deemed University) has officially announced the results of the Symbiosis Entrance Test (SET) 2025 today, May 22. Candidates who appeared for either Test 01 or Test 02 can now access their individual scorecards by visiting the official SET website — The scorecards are available through candidate login using the credentials generated during registration. The university has released the results for both Test 01 and Test 02 on the same day. Candidates who were scheduled to take the exam on May 11 but experienced postponement will be issued revised exam dates separately, as per university guidelines. SET 2025 result: Steps to access To access their SET 2025 results, candidates must follow these steps: Visit the official website at Click on the 'Download SET Scorecard' link available on the homepage. Enter your SET ID and password. View your scorecard and verify all details. Download and print the scorecard for future reference. Alternatively, candidates can click on the link provided here to download the SET result 2025. SET result 2025: What's next Candidates who meet the cutoff criteria will move on to the next stages of the admission process. These typically include: Personal Interaction (PI) Written Ability Test (WAT) Counselling and Seat Allocation The performance in SET 2025, combined with these subsequent rounds, will determine final admission to various Symbiosis undergraduate courses. Candidates are advised to stay in touch with the official website to get the latest updates regarding the SET examination 2025. Invest in Their Tomorrow, Today: Equip your child with the essential AI skills for a future brimming with possibilities | Join Now
